학술논문
'학술논문'
에서 검색결과 235,793건 | 목록
1~10
Academic Journal
Yu-Lun Chen / 陳育倫; Yu-Min Yeh / 葉裕民; Wen-Chien Ting / 丁文謙; Ren-Hao Chan / 詹仁豪; Po-Chuan Chen / 陳柏全; Chun-Hsien Wu / 吳俊賢; Bo-Wen Lin / 林博文
中華民國大腸直腸外科醫學會雜誌. Vol. 35 Issue 2, p78-85. 8 p.
Report
A Prospective, Randomized, Controlled, Double-blind, Multi-center Clinical Study of Nimotuzumab Combinated With Gemcitabine Contrast to Placebo Combinated With Gemcitabine in K -RAS Wild -type,Locally Advanced and Metastatic Pancreatic Cancer
Report
Quality of life (QoL) assessment in patients (pts) with K -RAS wild -type (WT) chemotherapy refractory metastatic colorectal cancer (mCRC) treated with cetuximab (CET) plus brivanib alaninate (BRIV) or placebo: Results of the NCIC Clinical Trials Group and AGITG CO.20 trial. J Clin Oncol 30, 2012 (suppl 4; abstr 542). Jolie Ringash, Heather-Jane Au, Lillian L. Siu, Jeremy D. Shapiro, Derek J. Jonker, John Raymond Zalcberg, Malcolm J. Moore, Andrew H. Strickland, Rami Kotb, Mark Jeffery, Thierry Alcindor, Siobhan Ng, Muhammad Salim, Sabe S. Sabesan, Jacob C. Easaw, Jennifer Anne Shannon, Fabyolla El-Tahche, Ian B. Walters, Dongsheng Tu, Christopher J. O'Callaghan.
Phase III randomized trial of cetuximab (CET) plus either brivanib alaninate (BRIV) or placebo in patients (pts) with metastatic (MET) chemotherapy refractoryK -RAS wild -type (WT) colorectal carcinoma (CRC): The NCIC Clinical Trials Group and AGITG CO.20 trial. J Clin Oncol 30, 2012 (suppl 4; abstr 386). Lillian L. Siu, Jeremy D. Shapiro, Derek J. Jonker, Christos Stelios Karapetis, John Raymond Zalcberg, John Simes, Felix Couture, Malcolm J. Moore, Timothy Jay Price, Jehan Siddiqui, Louise M. Nott, Danielle Charpentier, Winston S. Liauw, Michael B. Sawyer, Michael Jefford, Nadine M Magoski, Andrew Mark Haydon, Ian B. Walters, Dongsheng Tu, Christopher J. O'Callaghan.
Final analysis of the phase III randomized trial of cetuximab (CET) plus either brivanib alaninate (BRIV) or placebo in patients (pts) with chemotherapy refractory,K -RAS wild -type (WT), metastatic colorectal carcinoma (mCRC): The NCIC Clinical Trials Group and AGITG CO.20 trial. J Clin Oncol 30, 2012 (suppl; abstr 3504). Lillian L. Siu, Jeremy David Shapiro, Derek J. Jonker, Christos Stelios Karapetis, John Raymond Zalcberg, John Simes, Felix Couture, Malcolm J. Moore, Timothy Jay Price, Jehan Siddiqui, Louise M. Nott, Danielle Charpentier, Winston S. Liauw, Michael B. Sawyer, Michael Jefford, Nadine M Magoski, Andrew Mark Haydon, Ian B. Walters, Dongsheng Tu, Christopher J. O'Callaghan.
Analysis of plasma biomarkers potentially associated with antiangiogenic resistance in NCIC CTG/AGITG CO.20: A phase III randomized trial of cetuximab (CET) plus either brivanib alaninate (BRIV) or placebo in patients (pts) with chemotherapy refractory,k -RAS wild -type (WT), metastatic colorectal carcinoma (mCRC). J Clin Oncol 30, 2012 (suppl; abstr 3572). Jeremy David Shapiro, Lillian L. Siu, Christopher J O'Callaghan, John Raymond Zalcberg, Malcolm J. Moore, Timothy Jay Price, Catherine Doyle, John Simes, Brian Peter Findlay, Michelle F. Cronk, Asif Shaikh, Warren Lance Joubert, Benoit Samson, Antonino Bonaventura, Craig Underhill, David Wyld, Ian B. Walters, Penny Phillips, Dongsheng Tu, Derek J. Jonker.
Siu LL, Shapiro JD, Jonker DJ, Karapetis CS, Zalcberg JR, Simes J, Couture F, Moore MJ, Price TJ, Siddiqui J, Nott LM, Charpentier D, Liauw W, Sawyer MB, Jefford M, Magoski NM, Haydon A, Walters I, Ringash J, Tu D, O'Callaghan CJ. Phase III randomized, placebo-controlled study of cetuximab plus brivanib alaninate versus cetuximab plus placebo in patients with metastatic, chemotherapy-refractory,wild -type K -RAS colorectal carcinoma: the NCIC Clinical Trials Group and AGITG CO.20 Trial. J Clin Oncol. 2013 Jul 1;31(19):2477-84. doi: 10.1200/JCO.2012.46.0543. Epub 2013 May 20.
A Phase III Randomized Study of Brivanib Alaninate (BMS-582664) in Combination With Cetuximab (Erbitux®) Versus Placebo in Combination With Cetuximab (Erbitux®) in Patients WithK -RAS Wild Type Tumors Previously Treated With Combination Chemotherapy for Metastatic Colorectal Carcinoma
Phase III randomized trial of cetuximab (CET) plus either brivanib alaninate (BRIV) or placebo in patients (pts) with metastatic (MET) chemotherapy refractory
Final analysis of the phase III randomized trial of cetuximab (CET) plus either brivanib alaninate (BRIV) or placebo in patients (pts) with chemotherapy refractory,
Analysis of plasma biomarkers potentially associated with antiangiogenic resistance in NCIC CTG/AGITG CO.20: A phase III randomized trial of cetuximab (CET) plus either brivanib alaninate (BRIV) or placebo in patients (pts) with chemotherapy refractory,
Siu LL, Shapiro JD, Jonker DJ, Karapetis CS, Zalcberg JR, Simes J, Couture F, Moore MJ, Price TJ, Siddiqui J, Nott LM, Charpentier D, Liauw W, Sawyer MB, Jefford M, Magoski NM, Haydon A, Walters I, Ringash J, Tu D, O'Callaghan CJ. Phase III randomized, placebo-controlled study of cetuximab plus brivanib alaninate versus cetuximab plus placebo in patients with metastatic, chemotherapy-refractory,
A Phase III Randomized Study of Brivanib Alaninate (BMS-582664) in Combination With Cetuximab (Erbitux®) Versus Placebo in Combination With Cetuximab (Erbitux®) in Patients With
Academic Journal
Hernandez, Aleksandra (University of Miami)
Academic Journal
Ghatak, Swagata; Diedrich, Jolene K; Talantova, Maria; Bhadra, Nivedita; Scott, Henry; Sharma, Meetal; Albertolle, Matthew; Schork, Nicholas J; Yates, John R; Lipton, Stuart A
Advanced Science. 11(29)
Book
The De Gruyter Handbook of Artificial Intelligence, Identity and Technology Studies. 1:267-286
Audio
Academic Journal
Wang, Pan; Song, Xinhua; Utpatel, Kirsten; Shang, Runze; Yang, Yoon Mee; Xu, Meng; Zhang, Jie; Che, Li; Gordan, John; Cigliano, Antonio; Seki, Ekihiro; Evert, Matthias; Calvisi, Diego F; Hu, Xiaosong; Chen, Xin
Cell death & disease. 10(2)
Academic Journal
Qin, Shukui; Li, Jin; Bai, Yuxian; Wang, Zishu; Chen, Zhendong; Xu, Ruihua; Xu, Jianming; Zhang, Hongmei; Chen, Jia; Yuan, Ying; Liu, Tianshu; Yang, Lin; Zhong, Haijun; Chen, Donghui; Shen, Lin; Hao, Chunyi; Fu, Deliang; Cheng, Ying; Yang, Jianwei; Wang, Qiong; et al
Audio
Heifetz, Jascha, Arranger; Gershwin, George, Composer; Nestor, Gregg, Arranger; Kochanski, Paul, Composer; Szymanowski, Karol, Composer; Krantz, Allen, Arranger; Rodrigo, Joaquín, Composer; Ravel, Maurice, Composer; Korngold, Erich Wolfgang, Composer; Ponce, Manuel María, Composer; Williams, John, Composer; Foss, Lukas, Composer
검색 결과 제한하기
제한된 항목
[검색어] Wild, K.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어